Breaks Categories: News

WednesdayOct 25, 2017 9:26 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Enters MOU Related to Import and Distribution of Cannabinoid-Based Therapies in Germany

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH for the import and distribution of IGC’s cannabinoid-based therapies to pharmacies in Germany. Under the terms of the MOU, MediCann will provide the capital required for the transportation, import, storage, sales and marketing of products intended for the German market. “There are many benefits to developing a strong presence in the German pharmacy market including, a favorable regulatory environment and reimbursement from health insurance providers,”…

Continue Reading

TuesdayOct 24, 2017 12:27 pm

NetworkNewsBreaks – Recon Technology (NASDAQ: RCON) Shares Surge on $2M Supply and Services Deal with Qinghai Oilfield

Shares of Recon Technology (NASDAQ: RCON) are up 21% after the company this morning said it will provide its proprietary chemical compound agents, microbiological treatment agents and relevant services for oily sewage treatments to Qinghai Oilfield Company, a PetroChina Co., Ltd. subsidiary. The company expects to receive revenues of RMB 13.11 million (approximately USD $2 million) over the course of one year, dependent upon the quantity of the products actually used. "This is a major progression in our partnership with Qinghai Oilfield, and an indication of the upside potential of Recon in the oilfield environmental protection market," Recon chief executive…

Continue Reading

TuesdayOct 24, 2017 12:12 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Opens Fifth Testing Location in Eastern Oregon

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced the opening of its fifth testing location in eastern Oregon. “We are excited to announce our new location in La Grande, OR,” William Waldrop, CEO of EVIO, stated in the news release. “Oregon recently passed OAR 603-048 which requires all industrial hemp and hemp derived manufactured products to be tested by an accredited testing lab prior to being made available for sale. Our new location, is the only lab in eastern Oregon and is strategically located near a significant number of Oregon's 233 licensed hemp…

Continue Reading

TuesdayOct 24, 2017 11:43 am

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences

Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction. Located in Denver, Colorado, Eqova Life Sciences develops clinical-grade Full Spectrum Hemp Oil products that are sold exclusively via partnerships with licensed medical practitioners. Per the news release, no other hemp oil company currently focuses exclusively on the practitioner market, leaving it largely underserved. Included in the acquisition, Eqova has approximately $150,000 worth of CBD inventory, which is expected to be sold by the end of 2017. Eqova also has hundreds of relationships with suppliers, vendors…

Continue Reading

TuesdayOct 24, 2017 11:11 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Enhances Product Line

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a selection of premium honey products. Included in this selection are the company’s new honey packed straws, which are infused with 10mg of pure natural organic cannabidiol (CBD). Combining the potentially beneficial attributes of both cannabis and honey, Diamond CBD anticipates that these Infused Honey Sticks may offer a new way to enhance wellness and boost the immune system. This morning’s product announcement comes as Diamond CBD seeks to build on its recent success in recording strong financial…

Continue Reading

TuesdayOct 24, 2017 10:28 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) and AppSwarm, Inc. (SWRM) Enter LOI to Conduct Joint Roll-Out of Cannabis Mobile Apps

Specialized holding company SinglePoint, Inc. (OTC: SING) and technology development company AppSwarm, Inc. (OTC: SWRM) this morning announced their entry into a Letter of Intent related to a joint roll-out of mobile applications specifically geared to the cannabis industry. Per the update, the applications will be branded and marketed under SinglePoint’s SingleSeed subsidiary, while AppSwarm will provide the necessary technical support and app development expertise. “We are very excited to roll-out these applications,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “We have worked on projects like these before and now we really feel we have both the…

Continue Reading

TuesdayOct 24, 2017 10:02 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Teams with Pegasus Fintech, Inc. to Develop Cryptocurrency-Based Token

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has established a strategic partnership with Pegasus Fintech, Inc., an innovative blockchain and token accelerator company delivering regulatory-compliant solutions in the financial services, technology, blockchain and cryptocurrency market sectors. “MoneyTrac Technology is aiming to establish itself as the most effective full-service provider of financial technology solutions for businesses in the cannabis industry,” Vanessa Luna, COO of MoneyTrac, stated in the news release. “Pegasus’s cryptocurrency technology will serve as the catalyst for us to develop and introduce a cryptocurrency token that we…

Continue Reading

TuesdayOct 24, 2017 9:37 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Highlights Positive Pre-Clinical Data Related to Biosynthesis Platform

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia. Notably, this study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye resulting in enhanced drug uptake via the cornea and lens. “Importantly, this study offers further validation of InMed's capabilities in moving the science of cannabinoid pharmaceuticals forward,” Eric A. Adams, president and CEO of InMed, stated in the news release. “Results like this, combined with our expanding patent portfolio and list of publications, on-going R&D, and renowned…

Continue Reading

MondayOct 23, 2017 11:32 am

NetworkNewsBreaks – Dragon Victory International Ltd. (NASDAQ: LYL) Shares Climb During First Day of Trading on the Nasdaq Capital Market

Dragon Victory International’s (NASDAQ: LYL) ordinary shares began trading on the NASDAQ Capital Market on Friday, October 20, following the close of the company’s initial public offering (IPO). Boustead Securities, LLC acted as the lead underwriter for the offering, marking its third Nasdaq IPO of a Chinese company this year, all of which have been ranked among the top-performing IPOs of 2017. Dragon Victory had an impressive first day as shares began trading at $7.39 on Friday and climbed to $13.67, rising 128% during the company’s NASDAQ debut. “We are very excited with our first trading performance. Our team has…

Continue Reading

MondayOct 23, 2017 11:29 am

NetworkNewsBreaks – Agenus, Inc. (NASDAQ: AGEN) Launches New AgenTus Therapeutics Subsidiary, Names CEO

Shares of Agenus (NASDAQ: AGEN) are up 3.7% this morning after the company launched a new subsidiary company, AgenTus Therapeutics, Inc., for its cell therapy business. AgenTus will focus on the discovery, development, and commercialization of breakthrough immuno-oncology (I-O) "living drugs" to advance potential cures for cancer patients. Bruno Lucidi has been appointed as CEO of the AgenTus subsidiary. "AgenTus will operate with remarkable science, innovation, and access to Agenus capabilities and expertise, all giving the subsidiary competitive advantage through the delivery of innovative living drugs to cancer patients looking for cures," Agenus chairman and CEO Garo Armen, Ph.D. stated…

Continue Reading